Familial hypobetalipoproteinemia: spectrum of variants and phenotypic manifestations
https://doi.org/10.25557/2073-7998.2025.10.114-117
Abstract
Variants in the APOB gene are associated with the development of familial hypobetalipoproteinemia (FHBL), variants in the PCSK9, ANGPTL3, ANGPTL4, MTTP and SAR1B genes cause phenotypes similar to FHBL. The aim was to investigate the spectrum of variants associated with FHBL and other similar phenotypes in the «NMRC TPM» sample. The study sample: ESSE-RF participants (n = 3070) and patients of the Expert Center for Hereditary Dyslipidemias (n = 3063). Based on NGS data, the above genes associated with lipid metabolism disorders were analyzed, and the genetic risk scale (GRS) values of low-density lipoprotein cholesterol (LDL-C) were evaluated. A total of 20 variants were found in 34 individuals associated with the phenotypes under study, including 10 variants in the APOB gene (10 individuals), 3 in the PCSK9 gene (4 individuals), 3 in the ANGPTL3 gene (3 individuals), and 4 in the ANGPTL4 gene (17 individuals). All variants were detected in the heterozygous state. In 5 individuals, the LDL-C GHR value was below the 10th percentile. The median LDL-C value in the group was 2,31 (1,52 – 3,03) mmol/L. Carriers of variants in the APOB gene had significantly lower LDL-C levels than carriers of variants in other genes: 1.19±0.72 mmol/L and 2.69±1.09 mmol/L, respectively, p<0.001.
About the Authors
V. I. MikhailinaRussian Federation
10, bld. 3, Petroverigsky per., Moscow, 101000
A. N. Meshkov
Russian Federation
10, bld. 3, Petroverigsky per., Moscow, 101000
M. Zaichenoka
Russian Federation
9, Institutskiy per., Dolgoprudny, 14170
A. V. Kiseleva
Russian Federation
10, bld. 3, Petroverigsky per., Moscow, 101000
O. M. Drapkina
Russian Federation
10, bld. 3, Petroverigsky per., Moscow, 101000
References
1. Meshkov A.N., Ershova A.I., Kiseleva A.V., et al. Geneticheskiye aspekty nizkikh znacheniy kholesterina lipoproteinov nizkoy plotnosti [Genetic aspects of decreased low-density lipoprotein cholesterol values]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2023;22(12):3846. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3846..
2. Rodríguez de Vera-Gómez P., Del Pino-Bellido P., García-González J.J. et al. Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review. J Clin Lipidol. 2022;16(5):601-607. doi:10.1016/j.jacl.2022.07.008
Review
For citations:
Mikhailina V.I., Meshkov A.N., Zaichenoka M., Kiseleva A.V., Drapkina O.M. Familial hypobetalipoproteinemia: spectrum of variants and phenotypic manifestations. Medical Genetics. 2025;24(10):114-117. (In Russ.) https://doi.org/10.25557/2073-7998.2025.10.114-117






















